Please ensure Javascript is enabled for purposes of website accessibility

Core Laboratories Beats on Both Top and Bottom Lines

By Seth Jayson - Updated Apr 10, 2017 at 1:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Just the facts, Fool.

Core Laboratories (NYSE: CLB) reported earnings on April 17. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Core Laboratories beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew. GAAP earnings per share expanded.

Gross margins grew, operating margins grew, net margins contracted.

Revenue details
Core Laboratories reported revenue of $260.9 million. The 12 analysts polled by S&P Capital IQ foresaw revenue of $247.2 million on the same basis. GAAP reported sales were 11% higher than the prior-year quarter's $234.2 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.22. The 14 earnings estimates compiled by S&P Capital IQ forecast $1.15 per share. GAAP EPS of $1.22 for Q1 were 8.0% higher than the prior-year quarter's $1.13 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 37.3%, 100 basis points better than the prior-year quarter. Operating margin was 30.3%, 70 basis points better than the prior-year quarter. Net margin was 21.7%, 130 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $261.5 million. On the bottom line, the average EPS estimate is $1.26.

Next year's average estimate for revenue is $1.06 billion. The average EPS estimate is $5.15.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 631 members out of 643 rating the stock outperform, and 12 members rating it underperform. Among 124 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 124 give Core Laboratories a green thumbs-up, and give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Core Laboratories is outperform, with an average price target of $128.79.

Is Core Laboratories the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Core Laboratories N.V. Stock Quote
Core Laboratories N.V.
CLB
$24.47 (1.92%) $0.46

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
349%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.